Literature DB >> 34135480

BAX mitochondrial integration is regulated allosterically by its α1-α2 loop.

Michael A Dengler1,2,3, Leonie Gibson1, Jerry M Adams4,5.   

Abstract

The conformational changes converting BAX from an inert cytosolic monomer into the homo-oligomers that permeabilize the mitochondrial outer membrane (MOM) are crucial steps toward apoptosis. Here, we have explored the potential role of the BAX α1-α2 loop in this process by three mutagenic approaches: replacing loop segments with cognate loop regions from closely related proteins, alanine scanning and analysis of BAX α1-α2 loop missense mutations observed in tumours. Responsiveness to a death signal, such as tBID, was reduced by mutations in the N-terminal but not C-terminal half of the loop. N-terminal loop variants, which were enriched in tumours, impaired MOM integration by allosterically reducing exposure of the BAX α9 transmembrane anchor. Most C-terminal loop variants reduced BAX stability, leading to increased BAX apoptotic function in some variants. Thus, our systematic mutagenesis suggests that the two halves of the α1-α2 loop have distinct functions. We show that the N-terminal half of the loop (its first nine residues) comprises an important allosteric regulator of BAX activation by setting the proportion of MOM-integrated BAX following a death signal. The enrichment of N-terminal loop mutations in tumours indicates that they may promote tumour cell survival and underscore the loop as a target for therapeutic manipulation of BAX function.
© 2021. The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34135480      PMCID: PMC8630029          DOI: 10.1038/s41418-021-00815-x

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  4 in total

Review 1.  Physiological and pharmacological modulation of BAX.

Authors:  Adam Z Spitz; Evripidis Gavathiotis
Journal:  Trends Pharmacol Sci       Date:  2021-11-27       Impact factor: 14.819

2.  A taste of the early steps in BAX activation with FLAMBE.

Authors:  Melanie Gil; Marina R Hanna; Vivian Gama
Journal:  Cell Rep Methods       Date:  2022-03-15

Review 3.  Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview.

Authors:  Andrea M Guida; Bruno Sensi; Vincenzo Formica; Rolando M D'Angelillo; Mario Roselli; Giovanna Del Vecchio Blanco; Piero Rossi; Gabriella T Capolupo; Marco Caricato; Giuseppe S Sica
Journal:  Biol Direct       Date:  2022-06-13       Impact factor: 7.173

4.  Structure of the BAK-activating antibody 7D10 bound to BAK reveals an unexpected role for the α1-α2 loop in BAK activation.

Authors:  Adeline Y Robin; Michelle S Miller; Sweta Iyer; Melissa X Shi; Ahmad Z Wardak; Daisy Lio; Nicholas A Smith; Brian J Smith; Richard W Birkinshaw; Peter E Czabotar; Ruth M Kluck; Peter M Colman
Journal:  Cell Death Differ       Date:  2022-03-12       Impact factor: 12.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.